New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 25.07.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

July 26, 2024

Opinion | ‘Tip of a Billion-Dollar Claims Iceberg’: What We Heard This Week

“This is just the tip of a billion-dollar claims iceberg as there are hundreds of U.S. clinics that have fraudulently billed Medicare for these birth

February 5, 2024

Early Introduction of Peanuts Holds Up After Over a Decade

Children originally part of a peanut consumption trial maintained long-lasting peanut tolerance by age 12, a follow-up of the LEAP trial found. At 12 years

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.